South Middlesex Times

Women who conceive through in vitro fertilization (IVF) and experience serious pregnancy complications are twice as likely to deliver early compared to those with only one of these factors, according to a Rutgers Health researcher.

The study, published in JAMA Network Open, analyzed nearly 79 million hospital deliveries in the United States over two decades. It is the first to examine the combined effects of assisted reproductive technology (ART), such as IVF, and placental abruption on preterm delivery rates.

“It's crucial for patients undergoing IVF to be aware of all potential outcomes, especially given the stress they're already under," said Jennifer Zhang, the study's lead author and an obstetrics and gynecology resident at Rutgers Robert Wood Johnson Medical School.

The study utilized the National Inpatient Sample, encompassing hospital data from 48 states. Using data from 2000 to 2019, researchers identified more than 391,000 pregnancies that underwent assisted reproduction and more than 850,000 cases of placental abruption—a condition where the placenta separates from the uterus before delivery.

Researchers found that women who conceived through ART had a 42 percent higher risk of experiencing abruption compared with those who conceived naturally. They also found that women who conceived through ART had a 46 percent higher chance of experiencing preterm birth than those who conceived naturally.

When both risk factors were present, a synergistic effect occurred.

Researchers also reported racial and ethnic differences. White women who conceived through ART had a 42 percent higher risk of placental abruption. Hispanic women faced an even higher elevation in risk at 66 percent. In contrast, Black women who conceived through ART faced no elevation in abruption risk over Black women who conceived naturally.

These findings could have significant implications for clinical practice; however, Zhang cautioned against immediate changes based on a single study.

“We need prospective studies to confirm these results,” said Cande Ananth, chief of the Division of Epidemiology and Biostatistics in the Department of Obstetrics, Gynecology, and Reproductive Sciences at Rutgers Robert Wood Johnson Medical School and senior author of the study. “But it might influence how clinicians approach certain situations.”

For instance, doctors might be more inclined to take aggressive action when an IVF patient shows signs of placental abruption. Whether the type of infertility treatment and its duration affect placental abruption and preterm delivery may also be worthy considerations.

The research comes at a time when ART use is on the rise. According to the Centers for Disease Control and Prevention (CDC), about 2 percent of all U.S. infants are conceived using these technologies—up from less than 0.5 percent in 2000. As ART use has grown, so have concerns about its potential complications. “ART pregnancies are already associated with increased risks of conditions such as preeclampsia and small-for-gestational-age births,” said Zhang.

However, as a retrospective analysis of hospital data, this study has limitations: it couldn't account for all potential confounding factors or distinguish between different types of ART. The dataset likely underestimates the total number of ART pregnancies due to reliance on hospital coding practices which may not always capture this information accurately.

Despite these caveats, the findings underscore the need for careful monitoring of ART pregnancies when complications arise and highlight the complex interplay between fertility treatments and pregnancy outcomes.

Looking forward, researchers are examining other potential complications related to ART pregnancies. "We're examining the association between ART and stillbirth," Zhang said.